Photo of David Gandara taken from ilcn.org
Jul 27, 2024, 14:14
David Gandara: ODAC for the AEGEAN perioperative trial
David Gandara, Co-Director-Center for Experimental Therapeutics at UC Davis Comprehensive Cancer Center, shared a post on X:
“ODAC for the AEGEAN perioperative trial held today. WOW on mandating additional trials defining contribution of components when FDA has already approved KN671, with same design issue. No vote taken on approval or not? Consistency?”
Source: David Gandara/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 22, 2025, 16:27
Mar 22, 2025, 14:55
Mar 22, 2025, 14:41
Mar 22, 2025, 14:28
Mar 22, 2025, 13:46
Mar 22, 2025, 13:29
Mar 22, 2025, 13:16
Mar 22, 2025, 12:47
Mar 22, 2025, 12:27
Mar 22, 2025, 12:06